A new broad-spectrum antimicrobial peptide candidate GT-2 from Gastrodia elate

https://www.cas.cn/syky/202608/t20260804_5117880.shtml

https://www.nature.com/articles/s44259-026-00253-0

Antimicrobial peptides (AMPs) are promising candidates for anti-infective development, but their translation is often limited by the difficulty of achieving potent microbial membrane activity without damaging mammalian cells. Whole-genome data from *Gastrodia elata* (Tianma) combined with protein resource mining and generative AI-based design has led researchers to a broad-spectrum antimicrobial peptide candidate named GT-2.

The team computationally screened candidate peptide fragments derived from defense-related proteins in *Gastrodia elata*. Using the natural protein fragment GP-1 as a scaffold, they explored sequence space via the DeepAMP generative model and the D-POS optimization workflow to ultimately derive GT-2. *In vitro* experiments demonstrated that GT-2 exhibits inhibitory activity against *Candida albicans*, *Pseudomonas aeruginosa*, *Staphylococcus aureus*, *Escherichia coli*, and methicillin-resistant *Staphylococcus aureus* (MRSA), with minimum inhibitory concentrations (MIC) ranging from 4 to 32 μg/mL; it also disrupts microbial membranes and inhibits biofilm formation. At a concentration of 500 μg/mL, the hemolysis rate of GT-2 against rabbit red blood cells was less than 5%. Animal experiments showed that the peptide effectively cleared pathogenic bacteria from wounds in mice infected with *Pseudomonas aeruginosa*.

Mechanistic studies revealed that GT-2 readily forms helical structures and binds deeply within bacterial- and fungal-like membrane environments. In contrast, mammalian-like cell membrane environments—characterized by phosphatidylcholine and cholesterol—do not favor its effective insertion. This “lipid-dependent membrane binding” property enables GT-2 to effectively distinguish between pathogenic microorganisms and host cells.

By integrating plant genomic resources with AI-driven peptide design, this study offers a novel pathway for discovering antimicrobial lead molecules from unique biological resources and provides new insights into enhancing the pathogen selectivity of membrane-active antimicrobial peptides.

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year. Accept or Deny